Published in Eur J Biochem on September 15, 1989
Chlorophyll Biosynthesis. Plant Cell (1995) 2.85
Short leader sequences may be transferred from small RNAs to pre-mature mRNAs by trans-splicing in Euglena. EMBO J (1991) 1.85
Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria. J Clin Invest (1990) 1.04
The secretory pathway of protists: spatial and functional organization and evolution. Microbiol Rev (1996) 0.96
The presequence of Euglena LHCPII, a cytoplasmically synthesized chloroplast protein, contains a functional endoplasmic reticulum-targeting domain. Proc Natl Acad Sci U S A (1993) 0.96
Analysis of Euglena gracilis plastid-targeted proteins reveals different classes of transit sequences. Eukaryot Cell (2006) 0.93
The final step of pantothenate biosynthesis in higher plants: cloning and characterization of pantothenate synthetase from Lotus japonicus and Oryza sativum (rice). Biochem J (1999) 0.93
Mutagenesis of arginine residues in the catalytic cleft of Escherichia coli porphobilinogen deaminase that affects dipyrromethane cofactor assembly and tetrapyrrole chain initiation and elongation. Biochem J (1991) 0.93
Structure and expression of chloroplast-localized porphobilinogen deaminase from pea (Pisum sativum L.) isolated by redundant polymerase chain reaction. Plant Physiol (1993) 0.92
Studies on the mechanism of hydroxymethylbilane synthase concerning the role of arginine residues in substrate binding. Biochem J (1991) 0.91
The two major membrane skeletal proteins (articulins) of Euglena gracilis define a novel class of cytoskeletal proteins. J Cell Biol (1992) 0.90
Characterization of the unique intron-exon junctions of Euglena gene(s) encoding the polyprotein precursor to the light-harvesting chlorophyll a/b binding protein of photosystem II. Nucleic Acids Res (1994) 0.88
Cloning and sequencing of some genes responsible for porphyrin biosynthesis from the anaerobic bacterium Clostridium josui. J Bacteriol (1995) 0.87
Expression and subcellular location of the tetrapyrrole synthesis enzyme porphobilinogen deaminase in light-grown Euglena gracilis and three nonchlorophyllous cell lines. Proc Natl Acad Sci U S A (1991) 0.84
High frequency of mutations in exon 10 of the porphobilinogen deaminase gene in patients with a CRIM-positive subtype of acute intermittent porphyria. Am J Hum Genet (1992) 0.83
A possible role for short introns in the acquisition of stroma-targeting peptides in the flagellate Euglena gracilis. DNA Res (2010) 0.83
Purification and properties of porphobilinogen deaminase from Arabidopsis thaliana. Biochem J (1994) 0.81
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1989) 0.75
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52
Variation in general practitioners' referral rates to consultants. J R Coll Gen Pract (1987) 12.16
INTERNAL STRUCTURE AND NUCLEI IN CELLS OF ESCHERICHIA COLI AS SHOWN BY IMPROVED ELECTRON MICROSCOPIC TECHNIQUES. J Bacteriol (1949) 7.86
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet (2007) 6.29
Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol (1987) 5.96
Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A (1997) 4.70
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood (1998) 3.06
HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med (1997) 3.03
Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. Blood (2001) 2.61
Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care (2001) 2.53
A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg (1971) 2.46
Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity. Development (1990) 2.42
Quantitative detection of protein expression in single cells using droplet microfluidics. Chem Commun (Camb) (2007) 2.37
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol (1998) 2.37
Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci (1997) 2.33
Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci U S A (1998) 2.32
The Use of Sulphocyanate of Soda in High Blood Pressure. Can Med Assoc J (1928) 2.20
The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology (1994) 2.19
Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur J Immunol (1999) 2.15
Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell (1990) 2.10
t(8;21) myelodysplasia, an early presentation of M2 AML. Br J Haematol (1995) 2.08
Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol (2000) 1.96
Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med (1993) 1.92
Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol Reprod (2003) 1.91
Crystal structure of aspartate decarboxylase at 2.2 A resolution provides evidence for an ester in protein self-processing. Nat Struct Biol (1998) 1.89
Telomere directed fragmentation of mammalian chromosomes. Nucleic Acids Res (1993) 1.88
Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve (2001) 1.85
A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation. Am J Surg (1968) 1.72
Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood (1995) 1.68
Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis. Trends Genet (1995) 1.68
Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood (1997) 1.65
Multiple genes encoding the conserved CCAAT-box transcription factor complex are expressed in Arabidopsis. Plant Physiol (1998) 1.59
Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol (2002) 1.54
Management of hemorrhage after percutaneous renal surgery. J Urol (1995) 1.53
Ototoxicity induced by once-daily gentamicin. Lancet (1998) 1.48
Inhibition of protohaem ferro-lyase by N-substituted porphyrins. Structural requirements for the inhibitory effect. Biochem J (1980) 1.46
A Schwann cell mitogen accompanying regeneration of motor neurons. Nature (1997) 1.44
The detection by immunodiffusion of tumour associated antigenic components in extracts of human bronchongenic carcinoma. Br J Cancer (1975) 1.42
Nucleic acid concentrations in normal human plasma. Clin Chem (1972) 1.42
VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology (2007) 1.41
Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes Dev (1990) 1.32
A single precursor protein for ferrochelatase-I from Arabidopsis is imported in vitro into both chloroplasts and mitochondria. J Biol Chem (1997) 1.32
Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology (2011) 1.32
Use of paraffin wax embedded bone marrow trephine biopsy specimens as a source of archival DNA. J Clin Pathol (1992) 1.31
The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood (1995) 1.31
Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase. Biochem J (1979) 1.25
Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis (2000) 1.24
Investigations of rat liver uroporphyrinogen decarboxylase. Comparisons of porphyrinogens I and III as substrates and the inhibition by porphyrins. Biochem J (1981) 1.23
The importance of full participation: lessons from a national case-control study. Br J Cancer (2002) 1.22
Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens (2013) 1.22
Paraneoplastic myopathy: response to intravenous immunoglobulin. Neuromuscul Disord (2007) 1.22
Regulation of a stylar transmitting tissue-specific gene in wild-type and transgenic tomato and tobacco. Mol Gen Genet (1990) 1.21
The use of immunoadsorbent columns for the isolation of antibodies specific for antigens associated with human bronchogenic carcinoma. Br J Cancer (1974) 1.20
Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA. Tissue Antigens (1998) 1.20
Purification, N-terminal amino acid sequence and properties of hydroxymethylbilane synthase (porphobilinogen deaminase) from Escherichia coli. Biochem J (1986) 1.19
Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res (2000) 1.18
The sterols of the echinoderm Asterias rubens. Biochem J (1973) 1.18
Escherichia coli L-aspartate-alpha-decarboxylase: preprotein processing and observation of reaction intermediates by electrospray mass spectrometry. Biochem J (1997) 1.17
Germ tube and chlamydospore formation by Candida albicans on a new medium. J Clin Microbiol (1975) 1.17
Susceptibility to basal cell carcinoma: associations with PTCH polymorphisms. Ann Hum Genet (2004) 1.17
Gait analysis in a rat model of osteoarthrosis. Physiol Behav (1997) 1.15
Detection of bacteremia by an automated radiometric method and a tubed broth method. Ann Clin Lab Sci (1975) 1.14
Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci U S A (1996) 1.14
New prospects for human stem-cell therapy in the nervous system. Trends Neurosci (1999) 1.13
Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells. Blood (1990) 1.12
Use of adjustable sutures: a helpful modification. Ann Ophthalmol (1986) 1.12
Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors. Vox Sang (1995) 1.12
Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance. Oncogene (2001) 1.12
Neural differentiation of mouse embryonic stem cells. Biochem Soc Trans (2003) 1.11
Tandem overproduction and characterisation of the nuclease domain of colicin E9 and its cognate inhibitor protein Im9. Eur J Biochem (1994) 1.10
Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice. BMJ (2001) 1.09
Cutaneous infection with Mycobacterium abscessus. Br J Dermatol (1995) 1.08
The substrate specificity and stereochemistry, reversibility and inhibition of the 3-oxo steroid delta 4-delta 5-isomerase component of cholesterol oxidase. Biochem J (1977) 1.08
Sterol biosynthesis in the starfish Asterias rubens and Henricia sanguinolenta. Biochem J (1971) 1.07
Cloning and characterization of Tag 1, a tobacco anther beta-1,3-glucanase expressed during tetrad dissolution. Plant Mol Biol (1994) 1.06
Red tattoo reactions: X-ray microanalysis and patch-test studies. Br J Dermatol (1991) 1.06
Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med (1997) 1.06
Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. Carcinogenesis (1999) 1.06
The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood (1993) 1.05
Two different genes encode ferrochelatase in Arabidopsis: mapping, expression and subcellular targeting of the precursor proteins. Plant J (1998) 1.05
Experiences with the shikimate-pathway enzymes as targets for rational drug design. Biochem Soc Trans (2003) 1.05
The sequence of hemC, hemD and two additional E. coli genes. Nucleic Acids Res (1988) 1.03
Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics (1991) 1.03
Direct and sensitive detection of a human virus by rupture event scanning. Nat Biotechnol (2001) 1.02
The sterols of echinoderms. Proc R Soc Lond B Biol Sci (1972) 1.02
Genetic variation of basal iron status, ferritin and iron regulatory protein in mice: potential for modulation of oxidative stress. Biochem Pharmacol (2000) 1.01
Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients. Transplant Proc (2001) 1.00
Cholesterol oxidases: properties and applications. J Steroid Biochem (1976) 1.00
Help-seeking behaviour in patients with lymphoma. Eur J Cancer Care (Engl) (2008) 1.00
Multiple basal cell carcinomas and malignant melanoma following radiotherapy for ankylosing spondylitis. Clin Exp Dermatol (2000) 0.99
Survival from childhood acute lymphoblastic leukaemia: the impact of social inequality in the United Kingdom. Eur J Cancer (2012) 0.99
Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiol Biomarkers Prev (1996) 0.99
Evidence from kinetic isotope studies for an enolate intermediate in the mechanism of type II dehydroquinases. Biochem J (1996) 0.98
Attitudes to prescribing iron supplements in general practice. Br Med J (Clin Res Ed) (1987) 0.97
Drugs and the hepatic porphyrias. Clin Haematol (1980) 0.97
Mixed lymphoblastic-myelomonoblastic leukemia in treated Hodgkin's disease. Blood (1980) 0.97